A picture paints a thousand words....The catalyst for the turnaround was a report that Medicago, a Pentagon-funded Canadian biopharmaceutical company “has produced a COVID-19 vaccine….The company's CEO, Bruce Clark, said his company could produce as many as 10 million doses a month.” While the vaccine won’t be ready until November, it offers hope that if this season’s outbreak can be contained/managed, next season’s will have less impact.

Screenshot-2020-03-13-08.13.19.png

Disclaimer: The material provided is for information purposes only and should not be considered as investment advice. The views, information, or opinions expressed in the text belong solely to the author, and not to the author’s employer, organization, committee or other group or individual or company.

High Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% and 70% of retail investor accounts lose money when trading CFDs with Tickmill UK Ltd and Tickmill Europe Ltd respectively. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.